Sign in

Nordson Corporation NDSN

Price 317.5 USD
as of 2026-09-04
53/100
No view
Quality55
Growth52
Balance-sheet strength60
Valuation36
Momentum62
Income54

Composite 53/100; the shares have moved about 25% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Valuation ranks 36/100 — a moderate mark against it.

Case for

Momentum ranks 62/100 — a slight point in its favour. Balance-sheet strength ranks 60/100 — a slight point in its favour. Quality ranks 55/100 — a slight point in its favour.

Case against

Valuation ranks 36/100 — a moderate mark against it.

What the company does Nordson Corporation engineers and markets precision dispensing, coating, and control systems for adhesives, coatings, polymers, and biomaterials across Industrial Precision Solutions and Medical and Fluid Solutions segments.

Key financials Nordson reports ROE 18%, ROA 9%, ROCE 15%, gross margin 55%, operating margin 27%, and net margin 19%. Revenue grew 4% and EPS 5% year-over-year. Debt/Equity is 0.56 and interest coverage 7.0x.

Stock health SiderAvis scores Quality 70, Growth 56, Strength 67, Valuation 30, Momentum 64, and Income 47. Piotroski F-Score is 7/9 and Altman Z is 6.26. The dividend yield is 1.2% with 23% payout.

Price vs fair value The stock trades at a discount of 7.70% versus the analyst mean target of 349.71. - Recent dividend increase of 15% marks 63 consecutive years of annual increases (2026-08-27). - Q2 earnings call highlighted five analyst questions on growth drivers (2026-08-26). - Media coverage emphasizes strong momentum and bullish sentiment (2026-08-28).

Looking forward Forward P/E is 25.45 and PEG is 0.88, suggesting earnings growth may not yet be fully priced. EV/EBITDA of 22.06 and FCF yield of 3.4% indicate balanced valuation metrics.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.